Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices 82401 

Controlled substance Drug 

code Schedule 

Morphine ....................................................................................................................................................................................... 9300 II 

Thebaine ....................................................................................................................................................................................... 9333 II 

Levo-alphacetylmethadol .............................................................................................................................................................. 9648 II 

Oxymorphone ............................................................................................................................................................................... 9652 II 

Thiafentanil ................................................................................................................................................................................... 9729 II 

Alfentanil ....................................................................................................................................................................................... 9737 II 

Sufentanil ...................................................................................................................................................................................... 9740 II 

Carfentanil .................................................................................................................................................................................... 9743 II 

Fentanyl ........................................................................................................................................................................................ 9801 II 

The company plans to manufacture 

bulk controlled substances for use in 

analytical testing. In reference to drug 

codes 7360 (Marihuana) and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetics. No other activities for 

these drug codes are authorized for this 

registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–25947 Filed 11–22–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1294] 

Importer of Controlled Substances 

Application: VHG Labs DBA LGC 

Standards 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: VHG Labs DBA LGC 

Standards has applied to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before December 26, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 26, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on November 6, 2023, 

VHG Labs DBA LGC Standards, 3 

Perimeter Road, Manchester, New 

Hampshire 03103–3341, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug code Schedule 

Amineptine (7-[(10,11-dihydro-5Hdibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) ........................................................ 1219 I 

Mesocarb (N-phenyl-N′-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) .............................................. 1227 I 

3-Fluoro-N-methylcathinone (3-FMC) ..................................................................................................................................... 1233 I 

4-Fluoro-N-methylcathinone (4-FMC) 1238 I N ..................................................................................................................... 1238 I 

Pentedrone (a-methylaminovalerophenone) .......................................................................................................................... 1246 I 

4-Methyl-N-ethylcathinone (4-MEC) ....................................................................................................................................... 1249 I 

Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478 I N .............................................................................. 1478 I 

N,N-Dimethylamphetamine .................................................................................................................................................... 1480 I 

Fenethylline ............................................................................................................................................................................ 1503 I 

4-Methylaminorex (cis isomer) ............................................................................................................................................... 1590 I 

4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4- 

methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).

1595 I 

Mecloqualone ......................................................................................................................................................................... 2572 I 

ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .................... 7010 I 

5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........................ 7011 I 

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................. 7012 I 

JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................................. 7019 I 

FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) .... 7021 I 

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................. 7023 I 

THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ........................................................................ 7024 I 

5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ................................ 7025 I 

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ....................... 7031 I 

5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ............... 7034 I 

5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ....................................... 7041 I 

MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .. 7042 I 

5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ........................................... 7049 I 


ddrumheller on DSK120RN23PROD with NOTICES1
82402 Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices 

Controlled substance Drug code Schedule 

4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 (1-(4- 

cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).

7089 I 

JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................................... 7173 I 

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................................. 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .............................................................................................................. 7201 I 

PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................................... 7222 I 

5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ..................................................................................... 7225 I 

N-ethylhexedrone 7246 I N .................................................................................................................................................... 7246 I 

Alpha-ethyltryptamine ............................................................................................................................................................. 7249 I 

2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine) .............................................................................. 7286 I 

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................................ 7297 I 

2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine ........................................................................................................ 7348 I 

2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) .................................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine ............................................................................................................................................... 7390 I 

4-Bromo-2,5-dimethoxyamphetamine .................................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................. 7392 I 

4-Methyl-2,5-dimethoxyamphetamine .................................................................................................................................... 7395 I 

2,5-Dimethoxy-4-ethylamphetamine ....................................................................................................................................... 7399 I 

3,4-Methylenedioxyamphetamine ........................................................................................................................................... 7400 I 

3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................. 7404 I 

Alpha-methyltryptamine .......................................................................................................................................................... 7432 I 

Diethyltryptamine .................................................................................................................................................................... 7434 I 

Dimethyltryptamine ................................................................................................................................................................. 7435 I 

5-Methoxy-N,N-diisopropyltryptamine .................................................................................................................................... 7439 I 

N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine ........................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ...................................................................................................................................... 7470 I 

N-Benzylpiperazine ................................................................................................................................................................ 7493 I 

2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ......................................................................................................... 7508 I 

2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ............................................................................................................. 7509 I 

2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ................................................................................................................. 7518 I 

2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................... 7519 I 

2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ............................................................................................................ 7521 I 

2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ..................................................................................................... 7524 I 

2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ............................................................................................ 7532 I 

25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................ 7536 I 

25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................ 7537 I 

25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ................................................................. 7538 I 

N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ............................................................ 7543 I 

alpha-pyrrolidinopentiophenone (a-PVP) ............................................................................................................................... 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) ................................................................................................................................. 7546 I 

Ethylone .................................................................................................................................................................................. 7547 I 

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................................... 7694 I 

Difenoxin ................................................................................................................................................................................. 9168 I 

Nicomorphine ......................................................................................................................................................................... 9312 I 

Drotebanol .............................................................................................................................................................................. 9335 I 

U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ...................................................................... 9547 I 

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ......................................................................... 9551 I 

MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .......................................................................................................... 9560 I 

Acetylmethadol ....................................................................................................................................................................... 9601 I 

Alphameprodine ..................................................................................................................................................................... 9604 I 

Benzethidine ........................................................................................................................................................................... 9606 I 

Betameprodine ....................................................................................................................................................................... 9608 I 

Clonitazene ............................................................................................................................................................................. 9612 I 

Dextromoramide ..................................................................................................................................................................... 9613 I 

Isotonotazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) ................................... 9614 I 

Dimenoxadol ........................................................................................................................................................................... 9617 I 

Dimepheptanol ....................................................................................................................................................................... 9618 I 

Dimethylthiambutene .............................................................................................................................................................. 9619 I 

Dioxaphetyl butyrate ............................................................................................................................................................... 9621 I 

Dipipanone ............................................................................................................................................................................. 9622 I 

Etonitazene ............................................................................................................................................................................. 9624 I 

Ketobemidone ........................................................................................................................................................................ 9628 I 

Levomoramide ........................................................................................................................................................................ 9629 I 

Noracymethadol ..................................................................................................................................................................... 9633 I 

Normethadone ........................................................................................................................................................................ 9635 I 

Piritramide .............................................................................................................................................................................. 9642 I 

Racemoramide ....................................................................................................................................................................... 9645 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ............................................................................................................................. 9661 I 

Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)ethan-1-amine .......................................... 9757 I 

Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) ........................................ 9759 I 

Para-Fluorofentanyl ................................................................................................................................................................ 9812 I 

3-Methylfentanyl ..................................................................................................................................................................... 9813 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ................................................ 9824 I 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices 82403 

Controlled substance Drug code Schedule 

Beta-hydroxyfentanyl .............................................................................................................................................................. 9830 I 

Beta-hydroxy-3-methylfentanyl ............................................................................................................................................... 9831 I 

3-Methylthiofentanyl ............................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .................................................................... 9834 I 

Thiofentanyl ............................................................................................................................................................................ 9835 I 

Beta-hydroxythiofentanyl ........................................................................................................................................................ 9836 I 

Ocfentanil ............................................................................................................................................................................... 9838 I 

beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as b′-phenyl fentanyl; 3- 

phenylpropanoyl fentanyl).

9842 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ................................................................................. 9843 I 

Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ........................................................................ 9844 I 

Cyclopropyl Fentanyl .............................................................................................................................................................. 9845 I 

ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl 

fentanyl).

9846 I 

Nabilone ................................................................................................................................................................................. 7379 II 

Alphaprodine .......................................................................................................................................................................... 9010 II 

Levomethorphan ..................................................................................................................................................................... 9210 II 

Racemethorphan .................................................................................................................................................................... 9732 II 

Alfentanil ................................................................................................................................................................................. 9737 II 

The company plans to import the 

listed controlled substances for 

distribution for analytical testing 

purposes. No other activities for these 

drug codes are authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023-25989 Filed 11-22-23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1297] 

Bulk Manufacturer of Controlled 

Substances Application: Sigma Aldrich 

Research Biochemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Sigma Aldrich Research 

Biochemicals, Inc. has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 23, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 23, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on October 27, 2023, 

Sigma Aldrich Research Biochemicals, 

Inc., 400–600 Summit Drive, Burlington, 

Massachusetts 01803, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Lisdexamfetamine ......... 1205 I 

The company plans to manufacture 

the listed controlled substances as 

reference standards. No other activities 

for these drug codes are authorized for 

this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–25992 Filed 11–22–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB Number 1121–0330] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Law 

Enforcement Congressional Badge of 

Bravery 

AGENCY: Office of Justice Programs, 

Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Office of Justice 

Programs, Bureau of Justice Assistance 

(BJA), Department of Justice (DOJ), will 

be submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

was previously published in the Federal 

Register on September 15, allowing a 

60-day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

December 26, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact: Gregory Joy at 202–514–1369, 

Policy Advisor, Bureau of Justice 

Assistance, 810 7th Street NW, 


ddrumheller on DSK120RN23PROD with NOTICES1